News about "Array BioPharma"

Alembic Pharmaceuticals Receives USFDA Approval for Binimetinib Tablets

Alembic Pharmaceuticals Receives USFDA Approval for Binimetinib Tablets

Alembic Pharmaceuticals has received final USFDA approval for binimetinib tablets in 15 mg and 45 mg strengths and is eligible for 180 days of generic drug exclusivity.

Array BioPharma | 17/11/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members